Labcorp (LH) director John H. Sampson files Form 3 showing no beneficial ownership

Rhea-AI Filing Summary

Labcorp Holdings Inc. director John H. Sampson filed an initial ownership report on Form 3. The filing states that no securities of Labcorp Holdings Inc. are beneficially owned. The report is filed as a single reporting person in the capacity of director.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sampson John H

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/09/2026

3. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for John H. Sampson	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Labcorp (LH) Form 3 filed by John H. Sampson report?

The Form 3 for Labcorp (LH) reports that director John H. Sampson currently has no securities beneficially owned in the company. It serves as his initial ownership statement filed as a single reporting person and confirms a zero holding position.

What is John H. Sampson’s relationship to Labcorp (LH) in this Form 3?

The filing identifies John H. Sampson as a director of Labcorp Holdings Inc. He is not listed as an officer or 10% owner, and the Form 3 is filed by one reporting person reflecting this director role only.

Does the Labcorp (LH) Form 3 show any transactions or trades by John H. Sampson?

No, the Form 3 for Labcorp (LH) shows no transactions or trades. Both non-derivative and derivative securities tables contain no reported holdings, and the remarks section explicitly states that no securities are beneficially owned at this time.

Are any derivative securities reported for John H. Sampson in the Labcorp (LH) Form 3?

No derivative securities are reported for John H. Sampson in this Form 3. The derivative securities table is present but contains no entries, and the remarks confirm that no securities are beneficially owned, including derivative instruments.

Who signed the Labcorp (LH) Form 3 for John H. Sampson?

The Form 3 is signed by /s/ Kathryn W. Kyle as Attorney-in-Fact for John H. Sampson. This reflects the use of a power of attorney, identified in the remarks as Exhibit 24, to execute the filing on his behalf.